Hav­ing shipped its first bench­top gene edit­ing de­vices, In­scrip­ta draws an­oth­er $150M from deep in­vestor well

In­scrip­ta is one big step clos­er to reach­ing its am­bi­tious vi­sion of vast­ly scal­ing and de­moc­ra­tiz­ing ac­cess to gene edit­ing. And in­vestors have thrown in $150 mil­lion more to join the ride.

The first batch of Onyx, its bench­top sys­tem for genome en­gi­neer­ing, has been shipped to cus­tomers, the com­pa­ny said, en­abling sci­en­tists to con­duct au­to­mat­ed high-through­put gene edit­ing on a ma­chine about the size of a mi­crowave.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.